Companies that own XOMA Corp.
BVF Partners LP
1,502,800
17.92%
0
1.9%
06/30/2018
BlackRock Fund Advisors
418,799
4.99%
241,430
0%
06/30/2018
Opaleye Management, Inc.
320,200
3.82%
0
1.51%
06/30/2018
The Vanguard Group, Inc.
299,697
3.57%
38,663
0%
06/30/2018
Medical Strategy GmbH
142,183
1.7%
12,024
1.44%
11/30/2017
Apo Asset Management GmbH
123,740
1.48%
8,169
0.09%
06/29/2018
Acadian Asset Management LLC
96,051
1.14%
39,672
0.01%
06/30/2018
OxFORD Asset Management LLP
88,025
1.05%
-28,092
0.04%
06/30/2018
SSgA Funds Management, Inc.
86,825
1.03%
86,825
0%
06/30/2018
Geode Capital Management LLC
84,690
1.01%
25,929
0%
06/30/2018
| Address |
2200 Powell Street
Emeryville California 94608
United States
|
|
Employees
|
- |
| Website |
http://www.xoma.com |
| Updated |
07/08/2019 |
| XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. |
